ArticleActa pharmacologica Sinica2024

Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma.

Qi-Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.